Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechNavio | PRODUCT CODE: 1238707

Cover Image

PUBLISHER: TechNavio | PRODUCT CODE: 1238707

Global Ibuprofen API Market 2023-2027

PUBLISHED:
PAGES: 151 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2500
PDF (Enterprise License)
USD 4000

Add to Cart

Technavio has been monitoring the ibuprofen API market and is forecast to grow by $31.68 mn during 2022-2027, accelerating at a CAGR of 2.53% during the forecast period. Our report on the ibuprofen API market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing geriatric population, evolving API manufacturing scenario in developing countries, and increase in pharmaceutical and biopharmaceutical production.

Technavio's ibuprofen API market is segmented as below:

By End-user

  • Pharmaceutical companies
  • Contract manufacturing organizations

By Product

  • Prescription
  • Over-the-counter

By Geography

  • Asia
  • North America
  • Europe
  • Rest of World (ROW)

This study identifies the paradigm shift in API manufacturing as one of the prime reasons driving the ibuprofen API market growth during the next few years. Also, increase in the R&D investments by ibuprofen API manufacturers and increase number of CEP approval for the manufacture of ibuprofen API will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the ibuprofen API market covers the following areas:

  • Ibuprofen API market sizing
  • Ibuprofen API market forecast
  • Ibuprofen API market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading ibuprofen API market vendors that include Arch Pharmalabs Ltd., Athos Chemicals Pvt. Ltd., Azelis SA, BASF SE, Chemino Pharma Ltd., Dr Reddys Laboratories Ltd., Granules India Ltd., HELM AG, IOL Chemicals and Pharmaceuticals Ltd., Mallinckrodt Plc, Octavius Pharma Pvt Ltd., Piramal Enterprises Ltd., Rochem International Inc., SI Group Inc., Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd., Solara Active Pharma Sciences Ltd., Strides Pharma Science Ltd., Teva Pharmaceutical Industries Ltd., Titan Lab Pvt Ltd., and Otto Brandes GmbH. Also, the ibuprofen API market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR75040

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market by Geography
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global ibuprofen API market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on Global ibuprofen API market 2017 - 2021 ($ million)
  • 4.2 End user Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - End user Segment 2017 - 2021 ($ million)
  • 4.3 Product Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

  • 6.1 Market segments
  • Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
  • 6.2 Comparison by End-user
  • Exhibit 32: Chart on Comparison by End-user
  • Exhibit 33: Data Table on Comparison by End-user
  • 6.3 Pharmaceutical companies - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Pharmaceutical companies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Pharmaceutical companies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Pharmaceutical companies - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Pharmaceutical companies - Year-over-year growth 2022-2027 (%)
  • 6.4 Contract manufacturing organizations - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Contract manufacturing organizations - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Contract manufacturing organizations - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Contract manufacturing organizations - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Contract manufacturing organizations - Year-over-year growth 2022-2027 (%)
  • 6.5 Market opportunity by End-user
  • Exhibit 42: Market opportunity by End-user ($ million)
  • Exhibit 43: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Product

  • 7.1 Market segments
  • Exhibit 44: Chart on Product - Market share 2022-2027 (%)
  • Exhibit 45: Data Table on Product - Market share 2022-2027 (%)
  • 7.2 Comparison by Product
  • Exhibit 46: Chart on Comparison by Product
  • Exhibit 47: Data Table on Comparison by Product
  • 7.3 Prescription - Market size and forecast 2022-2027
  • Exhibit 48: Chart on Prescription - Market size and forecast 2022-2027 ($ million)
  • Exhibit 49: Data Table on Prescription - Market size and forecast 2022-2027 ($ million)
  • Exhibit 50: Chart on Prescription - Year-over-year growth 2022-2027 (%)
  • Exhibit 51: Data Table on Prescription - Year-over-year growth 2022-2027 (%)
  • 7.4 Over-the-counter - Market size and forecast 2022-2027
  • Exhibit 52: Chart on Over-the-counter - Market size and forecast 2022-2027 ($ million)
  • Exhibit 53: Data Table on Over-the-counter - Market size and forecast 2022-2027 ($ million)
  • Exhibit 54: Chart on Over-the-counter - Year-over-year growth 2022-2027 (%)
  • Exhibit 55: Data Table on Over-the-counter - Year-over-year growth 2022-2027 (%)
  • 7.5 Market opportunity by Product
  • Exhibit 56: Market opportunity by Product ($ million)
  • Exhibit 57: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 59: Chart on Market share by geography 2022-2027 (%)
  • Exhibit 60: Data Table on Market share by geography 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 61: Chart on Geographic comparison
  • Exhibit 62: Data Table on Geographic comparison
  • 9.3 Asia - Market size and forecast 2022-2027
  • Exhibit 63: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 64: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 65: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 66: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.4 North America - Market size and forecast 2022-2027
  • Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.5 Europe - Market size and forecast 2022-2027
  • Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 India - Market size and forecast 2022-2027
  • Exhibit 83: Chart on India - Market size and forecast 2022-2027 ($ million)
  • Exhibit 84: Data Table on India - Market size and forecast 2022-2027 ($ million)
  • Exhibit 85: Chart on India - Year-over-year growth 2022-2027 (%)
  • Exhibit 86: Data Table on India - Year-over-year growth 2022-2027 (%)
  • 9.9 China - Market size and forecast 2022-2027
  • Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.10 Germany - Market size and forecast 2022-2027
  • Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.11 UK - Market size and forecast 2022-2027
  • Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity by geography
  • Exhibit 99: Market opportunity by geography ($ million)
  • Exhibit 100: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 101: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 103: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 104: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 105: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 106: Matrix on vendor position and classification
  • 12.3 Athos Chemicals Pvt. Ltd.
  • Exhibit 107: Athos Chemicals Pvt. Ltd. - Overview
  • Exhibit 108: Athos Chemicals Pvt. Ltd. - Product / Service
  • Exhibit 109: Athos Chemicals Pvt. Ltd. - Key offerings
  • 12.4 Azelis SA
  • Exhibit 110: Azelis SA - Overview
  • Exhibit 111: Azelis SA - Product / Service
  • Exhibit 112: Azelis SA - Key offerings
  • 12.5 BASF SE
  • Exhibit 113: BASF SE - Overview
  • Exhibit 114: BASF SE - Business segments
  • Exhibit 115: BASF SE - Key news
  • Exhibit 116: BASF SE - Key offerings
  • Exhibit 117: BASF SE - Segment focus
  • 12.6 Chemino Pharma Ltd.
  • Exhibit 118: Chemino Pharma Ltd. - Overview
  • Exhibit 119: Chemino Pharma Ltd. - Product / Service
  • Exhibit 120: Chemino Pharma Ltd. - Key offerings
  • 12.7 Dr Reddys Laboratories Ltd.
  • Exhibit 121: Dr Reddys Laboratories Ltd. - Overview
  • Exhibit 122: Dr Reddys Laboratories Ltd. - Business segments
  • Exhibit 123: Dr Reddys Laboratories Ltd. - Key offerings
  • Exhibit 124: Dr Reddys Laboratories Ltd. - Segment focus
  • 12.8 Granules India Ltd.
  • Exhibit 125: Granules India Ltd. - Overview
  • Exhibit 126: Granules India Ltd. - Product / Service
  • Exhibit 127: Granules India Ltd. - Key news
  • Exhibit 128: Granules India Ltd. - Key offerings
  • 12.9 IOL Chemicals and Pharmaceuticals Ltd.
  • Exhibit 129: IOL Chemicals and Pharmaceuticals Ltd. - Overview
  • Exhibit 130: IOL Chemicals and Pharmaceuticals Ltd. - Business segments
  • Exhibit 131: IOL Chemicals and Pharmaceuticals Ltd. - Key offerings
  • Exhibit 132: IOL Chemicals and Pharmaceuticals Ltd. - Segment focus
  • 12.10 Octavius Pharma Pvt Ltd.
  • Exhibit 133: Octavius Pharma Pvt Ltd. - Overview
  • Exhibit 134: Octavius Pharma Pvt Ltd. - Product / Service
  • Exhibit 135: Octavius Pharma Pvt Ltd. - Key offerings
  • 12.11 Piramal Enterprises Ltd.
  • Exhibit 136: Piramal Enterprises Ltd. - Overview
  • Exhibit 137: Piramal Enterprises Ltd. - Business segments
  • Exhibit 138: Piramal Enterprises Ltd. - Key offerings
  • Exhibit 139: Piramal Enterprises Ltd. - Segment focus
  • 12.12 Rochem International Inc.
  • Exhibit 140: Rochem International Inc. - Overview
  • Exhibit 141: Rochem International Inc. - Product / Service
  • Exhibit 142: Rochem International Inc. - Key offerings
  • 12.13 SI Group Inc.
  • Exhibit 143: SI Group Inc. - Overview
  • Exhibit 144: SI Group Inc. - Product / Service
  • Exhibit 145: SI Group Inc. - Key offerings
  • 12.14 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd.
  • Exhibit 146: Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Overview
  • Exhibit 147: Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Product / Service
  • Exhibit 148: Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Key offerings
  • 12.15 Solara Active Pharma Sciences Ltd.
  • Exhibit 149: Solara Active Pharma Sciences Ltd. - Overview
  • Exhibit 150: Solara Active Pharma Sciences Ltd. - Product / Service
  • Exhibit 151: Solara Active Pharma Sciences Ltd. - Key offerings
  • 12.16 Strides Pharma Science Ltd.
  • Exhibit 152: Strides Pharma Science Ltd. - Overview
  • Exhibit 153: Strides Pharma Science Ltd. - Business segments
  • Exhibit 154: Strides Pharma Science Ltd. - Key offerings
  • Exhibit 155: Strides Pharma Science Ltd. - Segment focus
  • 12.17 Teva Pharmaceutical Industries Ltd.
  • Exhibit 156: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibit 157: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibit 158: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibit 159: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibit 160: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 161: Inclusions checklist
  • Exhibit 162: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 163: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 164: Research methodology
  • Exhibit 165: Validation techniques employed for market sizing
  • Exhibit 166: Information sources
  • 13.5 List of abbreviations
  • Exhibit 167: List of abbreviations
Product Code: IRTNTR75040

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market by Geography
  • Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on Global ibuprofen API market 2017 - 2021 ($ million)
  • Exhibits19: Historic Market Size - End user Segment 2017 - 2021 ($ million)
  • Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on End-user - Market share 2022-2027 (%)
  • Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by End-user
  • Exhibits33: Data Table on Comparison by End-user
  • Exhibits34: Chart on Pharmaceutical companies - Market size and forecast 2022-2027 ($ million)
  • Exhibits35: Data Table on Pharmaceutical companies - Market size and forecast 2022-2027 ($ million)
  • Exhibits36: Chart on Pharmaceutical companies - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Pharmaceutical companies - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on Contract manufacturing organizations - Market size and forecast 2022-2027 ($ million)
  • Exhibits39: Data Table on Contract manufacturing organizations - Market size and forecast 2022-2027 ($ million)
  • Exhibits40: Chart on Contract manufacturing organizations - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on Contract manufacturing organizations - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Market opportunity by End-user ($ million)
  • Exhibits43: Data Table on Market opportunity by End-user ($ million)
  • Exhibits44: Chart on Product - Market share 2022-2027 (%)
  • Exhibits45: Data Table on Product - Market share 2022-2027 (%)
  • Exhibits46: Chart on Comparison by Product
  • Exhibits47: Data Table on Comparison by Product
  • Exhibits48: Chart on Prescription - Market size and forecast 2022-2027 ($ million)
  • Exhibits49: Data Table on Prescription - Market size and forecast 2022-2027 ($ million)
  • Exhibits50: Chart on Prescription - Year-over-year growth 2022-2027 (%)
  • Exhibits51: Data Table on Prescription - Year-over-year growth 2022-2027 (%)
  • Exhibits52: Chart on Over-the-counter - Market size and forecast 2022-2027 ($ million)
  • Exhibits53: Data Table on Over-the-counter - Market size and forecast 2022-2027 ($ million)
  • Exhibits54: Chart on Over-the-counter - Year-over-year growth 2022-2027 (%)
  • Exhibits55: Data Table on Over-the-counter - Year-over-year growth 2022-2027 (%)
  • Exhibits56: Market opportunity by Product ($ million)
  • Exhibits57: Data Table on Market opportunity by Product ($ million)
  • Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits59: Chart on Market share by geography 2022-2027 (%)
  • Exhibits60: Data Table on Market share by geography 2022-2027 (%)
  • Exhibits61: Chart on Geographic comparison
  • Exhibits62: Data Table on Geographic comparison
  • Exhibits63: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits64: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits65: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits66: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits83: Chart on India - Market size and forecast 2022-2027 ($ million)
  • Exhibits84: Data Table on India - Market size and forecast 2022-2027 ($ million)
  • Exhibits85: Chart on India - Year-over-year growth 2022-2027 (%)
  • Exhibits86: Data Table on India - Year-over-year growth 2022-2027 (%)
  • Exhibits87: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits88: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits89: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibits90: Data Table on China - Year-over-year growth 2022-2027 (%)
  • Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits99: Market opportunity by geography ($ million)
  • Exhibits100: Data Tables on Market opportunity by geography ($ million)
  • Exhibits101: Impact of drivers and challenges in 2022 and 2027
  • Exhibits102: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits103: Overview on factors of disruption
  • Exhibits104: Impact of key risks on business
  • Exhibits105: Vendors covered
  • Exhibits106: Matrix on vendor position and classification
  • Exhibits107: Athos Chemicals Pvt. Ltd. - Overview
  • Exhibits108: Athos Chemicals Pvt. Ltd. - Product / Service
  • Exhibits109: Athos Chemicals Pvt. Ltd. - Key offerings
  • Exhibits110: Azelis SA - Overview
  • Exhibits111: Azelis SA - Product / Service
  • Exhibits112: Azelis SA - Key offerings
  • Exhibits113: BASF SE - Overview
  • Exhibits114: BASF SE - Business segments
  • Exhibits115: BASF SE - Key news
  • Exhibits116: BASF SE - Key offerings
  • Exhibits117: BASF SE - Segment focus
  • Exhibits118: Chemino Pharma Ltd. - Overview
  • Exhibits119: Chemino Pharma Ltd. - Product / Service
  • Exhibits120: Chemino Pharma Ltd. - Key offerings
  • Exhibits121: Dr Reddys Laboratories Ltd. - Overview
  • Exhibits122: Dr Reddys Laboratories Ltd. - Business segments
  • Exhibits123: Dr Reddys Laboratories Ltd. - Key offerings
  • Exhibits124: Dr Reddys Laboratories Ltd. - Segment focus
  • Exhibits125: Granules India Ltd. - Overview
  • Exhibits126: Granules India Ltd. - Product / Service
  • Exhibits127: Granules India Ltd. - Key news
  • Exhibits128: Granules India Ltd. - Key offerings
  • Exhibits129: IOL Chemicals and Pharmaceuticals Ltd. - Overview
  • Exhibits130: IOL Chemicals and Pharmaceuticals Ltd. - Business segments
  • Exhibits131: IOL Chemicals and Pharmaceuticals Ltd. - Key offerings
  • Exhibits132: IOL Chemicals and Pharmaceuticals Ltd. - Segment focus
  • Exhibits133: Octavius Pharma Pvt Ltd. - Overview
  • Exhibits134: Octavius Pharma Pvt Ltd. - Product / Service
  • Exhibits135: Octavius Pharma Pvt Ltd. - Key offerings
  • Exhibits136: Piramal Enterprises Ltd. - Overview
  • Exhibits137: Piramal Enterprises Ltd. - Business segments
  • Exhibits138: Piramal Enterprises Ltd. - Key offerings
  • Exhibits139: Piramal Enterprises Ltd. - Segment focus
  • Exhibits140: Rochem International Inc. - Overview
  • Exhibits141: Rochem International Inc. - Product / Service
  • Exhibits142: Rochem International Inc. - Key offerings
  • Exhibits143: SI Group Inc. - Overview
  • Exhibits144: SI Group Inc. - Product / Service
  • Exhibits145: SI Group Inc. - Key offerings
  • Exhibits146: Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Overview
  • Exhibits147: Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Product / Service
  • Exhibits148: Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Key offerings
  • Exhibits149: Solara Active Pharma Sciences Ltd. - Overview
  • Exhibits150: Solara Active Pharma Sciences Ltd. - Product / Service
  • Exhibits151: Solara Active Pharma Sciences Ltd. - Key offerings
  • Exhibits152: Strides Pharma Science Ltd. - Overview
  • Exhibits153: Strides Pharma Science Ltd. - Business segments
  • Exhibits154: Strides Pharma Science Ltd. - Key offerings
  • Exhibits155: Strides Pharma Science Ltd. - Segment focus
  • Exhibits156: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibits157: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibits158: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibits159: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits160: Teva Pharmaceutical Industries Ltd. - Segment focus
  • Exhibits161: Inclusions checklist
  • Exhibits162: Exclusions checklist
  • Exhibits163: Currency conversion rates for US$
  • Exhibits164: Research methodology
  • Exhibits165: Validation techniques employed for market sizing
  • Exhibits166: Information sources
  • Exhibits167: List of abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!